The average estimated risk of human immunodeficiency virus (HIV) infection for health care workers following a percutaneous or mucous exposure is õ0.5% in incidence studies, although a case-control study suggests it is much higher for highest-risk percutaneous exposure. To characterize exposures resulting in HIV transmission, we reviewed available data on occupational cases reported worldwide, identifying 94 documented and 170 possible cases. The majority of documented infections occurred in nurses, after contact with the blood of a patient with AIDS by means of percutaneous exposure, with a device placed in an artery or vein. High-exposure job categories, e.g., midwives and surgeons, are represented mostly among possible cases. Transmission occurred also through splashes, cuts, and skin contaminations, and in some cases despite postexposure prophylaxis with zidovudine. Health care workers could benefit if these data were incorporated in educational programs designed to prevent occupational bloodborne infections.
Awareness of the risk of occupational transmission of HIV as factors associated with HIV transmission. These factors are surrogates for an increased volume of blood or increased HIV to health care workers (HCWs) dates back to December 1984, when the first case of needlestick-transmitted HIV infection titers in the source patient. In a small percentage of cases of exposure involving two or more of these factors, the risk could was reported [1] . Evidence from local and national surveillance systems established from 1983 onward to provide prospective be much higher than 0.5%. In addition, case HCWs were significantly less likely to have taken postexposure prophylaxis data suggests that, for a single percutaneous exposure, the overall transmission rate is õ0.5% [2, 3] .
(PEP) with zidovudine than were control HCWs. However, the CCS mentioned above had some limitations, It is difficult, however, even with use of prospective studies or meta-analyses, to identify all the factors that may affect primarily because of the retrospective ascertainment of information about cases, the small number of cases, possible recall HIV transmission, because the transmission risk is low and the number of variables is large. For example, to evaluate at an and reporting biases, and the fact that all of the controls were from the United States while cases were also from other coun-80% power and a 95% significance level whether the risk of HIV transmission following parenteral exposure is 50% higher tries. Moreover, the CCS was limited to percutaneous exposures and did not take into consideration other exposures such than that after a mucocutaneous exposure would require about 70,000 HIV exposures for each group.
as mucous membrane or nonintact skin contaminations, which occur frequently in the health care setting. The recently published international case-control study (CCS) of HIV seroconversion in HCWs after percutaneous Descriptive information about exposure events that result in occupational transmission remains essential for further characexposure to HIV-infected blood [4] examined variables potentially important for transmission prevention. By means of logisterization of the principal factors associated with an increased risk of seroconversion. This review gathers the available data tic regression analysis, the CCS identified a ''deep'' injury, an injury by a device visibly contaminated with the source pafrom all cases of occupationally acquired HIV infection, with and without documented seroconversion, reported worldwide tient's blood, a procedure involving a needle placed directly in a vein or artery, and terminal illness in the source patient through September 1997, and it compares the findings with those of the CCS [4] . This report is intended to be a resource for those who provide occupational care to HCWs.
mented and possible. A documented case of occupational HIV Documented infections in the US account for Ç56% of infection was defined as one in which the HCW was reported cases; 32 cases (34%) were reported in Europe (table 1) . As to have percutaneous or mucocutaneous exposure to biological material from a patient with HIV infection or to cultured HIV, with (1) documented seroconversion (i.e., absence of HIV in- Table 1 tially contaminated with HIV and (2) no evidence of behavioral In 8 cases the source patient was asymptomatic, in 4 the patient was symptomatic but did not have AIDS, and in 1 (case 8) from the US (where this job category includes phlebotomists) and for 1 in 5 of the cases overall. Nine were doctors, and the exposure occurred during the ''window period,'' when the source patient had detectable HIV antigen but not antibodies one was a surgeon. Available data regarding the 94 cases are summarized in table 3. Seroconversion was documented in 91 to HIV. In 18 cases HIV infection occurred in spite of a complete cases, while in three laboratory workers exposed to concentrated HIV (cases 14, 55, and 56), the source of the infection or partial course of PEP with zidovudine (table 4) . In two-thirds (64) of the 94 cases, the time of the first positive was confirmed by sequencing.
Most infections (82 of 94; 87.2%) followed a single percutatest for antibodies to HIV was reported. Seroconversion within 6 months of exposure was documented in 57 case patients neous injury, including exposures to blood (74 cases), to visibly bloody body fluid (cases 3 and 51), to concentrated HIV (case (89%); of these, 42 had been tested and found to be seropositive by 3 months following exposure. Of the 15 first found to be 14), and to an unspecified source (cases 18, 22, 40, 42, and 47). Case patient 12 had sustained two separate percutaneous seropositive at 6 months post-exposure, only two (cases 9 and 31) had been tested at 104 days and 42 days post-exposure, exposures, and case patients 6 and 52 had had both percutaneous and mucocutaneous exposure to blood. Eight infections respectively. In eight cases, antibodies to HIV were first detected at more than 6 months post-exposure; one (case 18) had occurred after mucocutaneous exposure to blood (cases 5, 7, 13, 54, 69, and 73, plus one not reported in detail) or to concenbeen tested at 3 but not 6 months following exposure, and four (cases 47, 52, 61, and 66) had a documented negative test for trated HIV (case 56). In case 55 the means of exposure to concentrated HIV was unknown.
HIV antibodies at 6 months post-exposure. One (case 66) was retested on presentation with an AIDS-defining illness 18 In three-quarters (63) of the 82 seroconversions that followed a single percutaneous exposure, the device causing the injury months after exposure. An acute retroviral illness occurred in 42 case patients, inwas described or further information about the injury was provided. However, in seven cases the injury was described only cluding 15 of the 18 who received a complete or partial course of PEP with zidovudine. In 33 (79%) of these, the onset of as a needlestick, and one (case 71) was caused by an unknown sharp object protruding from a non-puncture-resistant consymptoms occurred within 6 weeks of exposure (median, 22 days; range, 11 days to 6 months). Two also had symptoms tainer. Seven infections followed a cut or an injury caused by / 9c61$$fe08 01-20-99 07:45:05 cida UC: CID NOTE. Ag Å antigen; AZT Å zidovudine; ddC Å zalcitabine; HBsAg Å hepatitis B surface antigen; HCV Å hepatitis C virus; HCW Å health care worker; HTLV-IIIB Å HIV adapted laboratory strain; IVDU Å iv drug use or user; NA Å data not available; / Å positive. * It is assumed that all cases from the US that have been published as case reports are included within the Centers for Disease Control and Prevention data.
suggestive of acute viral hepatitis. The absence of HIV-related Some of the early reports were of HCWs whose illness was symptoms was explicitly reported in 18 cases. In the remaining diagnosed as AIDS retrospectively (case 1), or who had been 36 cases, the presence or absence of HIV-related illness was exposed to HIV-infected patients before tests for HIV antibody not reported.
became widely available (e.g., cases 4, 5, 10, and 12) and before postexposure care procedures were well established. When a specific incident that might have resulted in infection was described, it was more frequently percutaneous exposure
Possible Occupational Infections
(32 cases) than mucocutaneous exposure (two cases). One infection (case 49) probably followed exposure during surgery Possible occupational infections were more widely distribon a patient with primary HIV infection acquired from transfuuted amongst different job categories than were documented sion. In 49% of the 45 cases for which the information was cases (tables 2 and 5). For example, nurses and clinical laboraavailable, the exposure incident associated with possible HIV tory workers together accounted for 70.2% (66) of the 94 docutransmission was not reported to employee health or other desmented cases but 37% (63) of the 170 possible cases, whereas ignated authorities. surgeons and dental workers accounted for 13.5% (23) Of note, six surgeons and two midwives among the possible cases had worked for extended periods during the early AIDS case may have been published as a case report (presented first as a conference abstract and subsequently in greater detail elseera in African countries, where and when the resources for provision of protective barrier garments were minimal and emwhere, usually in one but sometimes in two languages), as an incident case in a cohort study, and as a prevalent case in ployee health services for postexposure assessment and followup care were lacking. Finally, the rate of percutaneous exponational surveillance tables. Furthermore, case descriptions were not always consistent, and incomplete descriptions were sures involving hollow-bore, blood-filled needles is low in these professional groups because of the intrinsic characteristics of common.
For the possible cases, seroconversion was not observed and their jobs, which could account for a lower incidence of occupational transmission of HIV infection in these categories. occupational transmission could not be definitely established because the link between exposure and infection was far less
Of the four variables found to be significantly associated with viral transmission in the international CCS [4] , only one clear than in documented cases and the likelihood that nonoccupational, behavioral risk factors might have been present in (i.e., a procedure involving a needle placed in the source pa-/ 9c61$$fe08 01-20-99 07:45:05 cida UC: CID tient's artery or vein) was clearly evidenced in the present of circulating RNA copies. Moreover, the impact of highly active antiretroviral treatment [120] on the infectivity of HIVanalysis. The lack of details in the reporting of cases did not allow evaluation of the frequency of terminal illness in source infected patients should be evaluated, not only for percutaneous transmission but also for sexual or vertical transmission. patients (as defined in the CCS) the presence of visible blood on the device, or the depth of the injury. For the same reason, Eighteen cases of documented HIV infection occurred despite PEP with zidovudine. These cases have been ascribed the risk of infection associated with exposures that involved two or more of the risk factors identified by the CCS, which mainly to the increasing emergence of viral strains with reduced susceptibility to zidovudine. Other factors associated with treatmight be higher than the risk of each separate factor, cannot be evaluated. ment failure are delayed or low-dose treatment, treatment of short duration, and massive viral inoculum. However, since Other types of exposures that did not emerge or were not considered in the international CCS, such as injuries with solid most of the cases were reported anecdotally, the rate of failure is not well assessed, and a further explanation could be that sharps and splashes (which are very frequent among surgeons, for example), could be less efficient in transmitting HIV. Alzidovudine PEP is simply not 100% effective.
On the basis of these findings and the results of the CCS though inferences from data collected in a review that concern differential risk remain speculative because of the lack of de- [4] , which showed an 81% protective effect of zidovudine in preventing HIV transmission, public health agencies in develnominators or of a control group, the analysis of the cases reported in this review suggests that these kinds of exposures oped countries issued updated recommendations and defined new rules for risk assessment [121] . A combination of PEP carry a risk of transmission that is not negligible.
Despite a lack of data for some cases, an analysis of available with available antiretroviral agents is presently recommended because of its highest antiretroviral activity and to overcome information on the circumstances of exposures allows the identification of potentially preventable events, particularly with rethe increasing problem of resistance. A combination of at least two nucleoside reverse transcriptase inhibitors is recomspect to recommendations in the standard universal precautions [107, 108] , that are caused by the improper handling or disposal mended; for higher-risk exposure, another protease inhibitor can be added. of needles or the failure to employ appropriate barrier measures.
Other incidents happened under circumstances in which uniEven if the combination PEP is effective against resistant strains and overcomes the problem of a massive inoculum, the versal precautions were difficult to comply with, such as emergencies [109, 110], or in situations in which universal precaualready existing problem of early administration might remain unresolved. Moreover, because of the higher rate of adverse tions do not apply, such as a needlestick caused by an HCW bumping into a colleague, or in spite of application of universal effects and the complex treatment schedule, compliance with the recommended 4-week regimen could possibly worsen. The precautions, such as percutaneous injuries through gloves [111] . Whether used for the purpose of preventing mucocutaneimpact of combination PEP in modifying the characteristics of risk factors for occupational HIV transmission needs to be ous exposures or preventing parenteral exposures, universal precautions are extremely important; however, they are not assessed further with continuing surveillance. With regard to postexposure follow-up of HCWs, existing sufficient for preventing all exposure incidents.
The most promising approach for improving the safety of guidelines recommend clinical and serological baseline evaluation at the time of the exposure incident (time zero), first folHCWs is making physical modifications in the designs of sharp medical devices [97, 111 -114] . There is a special need to low-up appointments for testing and physical examination at 6 weeks and 3 months post-exposure, when both acute infection provide enhanced safety during vascular access procedures [97, 115] and during the disposal of needles and sharp objects. Six and seroconversion are most likely to occur [121] , and then at least once more at 6 months following exposure. Indeed, only of the documented HIV seroconversions occurred after injuries from intravenous catheter stylets, despite the fact that intraveeight cases occurred after this date, but only four of these patients had a negative HIV test at 6 months following exponous catheters represent only a small fraction of all needle devices used during the delivery of health care [116 -118] .
sure. In none of these could the delayed seroconversion be ascribed to zidovudine treatment. However, testing the HCW The international CCS [4] showed that terminal illness of the source patient is one of the most important factors affecting again at 1 year post-exposure can be considered for additional reassurance. the risk of HIV transmission, since the concentration of HIV in blood or other body substances varies during different stages With regard to the data collected in this review, some points should be considered. Publication bias may have affected reof infection [119] . The role of the clinical stage of HIV disease seems to be confirmed by the present analysis, in which, despite porting. Case reports may be unpublishable unless they describe something ''new.'' A chronological sequence can be lack of details, most source patients had AIDS and at least two were in the initial phase of infection. In the future, a greater discerned on examination of the substance of reports of documented cases. role in assessing the infectivity of the source could be played by HIV-RNA quantitative methods, in order to evaluate the The first report (from the UK, in 1984) of documented seroconversion in an HCW after percutaneous exposure was folrisk presented by the source patient with regard to the number / 9c61$$fe08 01-20-99 07:45:05 cida UC: CID lowed by reports from other countries confirming the phenomewith consequent loss of descriptive data. It is interesting that 3 of the 6 reports of seroconversion in HCWs following muconon. Later reports emphasized different aspects of occupational risk, highlighting the type of exposure (mucocutaneous expocutaneous exposure to blood were published in 1987/1988; there was a 9-year gap before reports (in 1996 and 1997) of sure, 1987); stage of infection of the source patient (window period, 1988); device causing the injury (lancet, 1990; scalpel, the 3 other cases, involving HCWs who had all received zidovudine as PEP. 1996); procedure-specific occupational risk (laboratory procedures, 1988; phlebotomy, 1992; dialysis, 1993; autopsy, 1997);
However, information about the cases is becoming increasingly important. Possible effects on occupational HIV transmisfailure of zidovudine prophylaxis (1990); delayed seroconversion (1994); concomitant transmission of other pathogens (hepsion rates induced by the use of combination therapy with new antiretroviral agents for the source patient and for the exposed atitis C virus, 1996); unusual disease progression (1997); and subsequent nosocomial infection due to immunosuppression HCW, as well as additional data on determinants of occupational infection with HIV, need to be evaluated in a timely (multidrug-resistant tuberculosis, 1997).
In parallel came reports of case series and of aggregate data manner. Therefore, biases and delays due to publication should be avoided. 
